Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Study of 5-FU Continuous Infusion (5-FUci) Versus CPT-11 Plus CDDP (CP) Versus S-1 Alone (S-1) in Advanced Gastric Cancer (JCOG9912)

NCT00142350 is registered in ClinicalTrials.gov with Japan Clinical Oncology Group as lead sponsor.

NCT NCT00142350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00142350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Study of 5-FU Continuous Infusion (5-FUci) Versus CPT-11 Plus CDDP (CP) Versus S-1 Alone (S-1) in Advanced Gastric Cancer (JCOG9912)
Lead sponsor
Japan Clinical Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2000
Completion date
January 31, 2007
Enrollment
690
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer